Key result
Adjunctive low-voltage area ablation cuts atrial tachyarrhythmia recurrence ~23% vs PVI alone without increasing serious complications.
Why the study?
Pulmonary vein isolation often yields suboptimal success, particularly in persistent AF, prompting evaluation of whether adjunctive low-voltage area ablation improves atrial tachyarrhythmia outcomes.
Does adjunctive low-voltage area (LVA) ablation reduce atrial tachyarrhythmia recurrence in patients with persistent atrial fibrillation undergoing PVI?
Meta-Analysis
Does adjunctive low-voltage area (LVA) ablation reduce atrial tachyarrhythmia recurrence in patients with persistent atrial fibrillation undergoing PVI?
Relative Risk: 0.768 (95% CI 0.655–0.898)
Adjunctive low-voltage area ablation during pulmonary vein isolation for persistent atrial fibrillation significantly reduces atrial tachyarrhythmia recurrence without increasing serious complications.
Supports adjunctive LVA ablation to reduce ATa recurrence in persistent AF; extends RCT evidence for strategy-specific substrate modification.
BACKGROUND: Pulmonary vein isolation (PVI) often yields suboptimal success, particularly in persistent atrial fibrillation (AF). This systematic review, frequentist meta-analysis, and Bayesian hierarchical meta-analysis evaluated whether adjunctive low-voltage area (LVA) ablation improves atrial tachyarrhythmia (ATa) outcomes, while assessing safety and potential effect modifiers. METHODS: PubMed, SCOPUS, and ScienceDirect were systematically searched for randomized controlled trials comparing PVI with versus without adjunctive LVA ablation. The primary outcome was ATa recurrence. Frequentist and Bayesian random-effects models, meta-regression, trial sequential analysis (TSA), and sensitivity analyses were performed. RESULTS: = 3.2%). Bayesian hierarchical meta-analysis demonstrated concordant findings (posterior pooled RR 0.768, 95% credible interval [CrI] 0.655-0.898) with minimal between-study heterogeneity (τ = 0.077, 95% CrI 0.004-0.241). Bayesian inference showed a 99.9% posterior probability of treatment benefit (RR<1.0), a 97.6% probability of ≥10% relative risk reduction, and a 90.8% probability of ≥15% reduction. Posterior predictive analysis yielded a 97.6% probability of benefit in a future trial. Leave-one-out and prior sensitivity analyses confirmed robust, data-driven results. Meta-regression identified no significant effect modifiers. Procedure and ablation times were not significantly prolonged, and serious complications were comparable between groups (RR 1.52, 95% CI 0.84-2.74; p = 0.169). TSA showed that 47% of the required information size had been accrued. Evidence certainty was moderate by GRADE. CONCLUSIONS: Adjunctive LVA ablation was associated with reduced ATa recurrence compared with PVI without adjunctive LVA ablation, with consistent findings across frequentist and Bayesian analyses, without increasing serious complications.
No takes yet. Share an insight, caveat, or question.
Pranata et al. (2026) conducted a meta-analysis in persistent atrial fibrillation. Adjunctive low-voltage area (LVA) ablation vs. PVI without adjunctive LVA ablation was evaluated on ATa recurrence (RR 0.768, 95% CI 0.655-0.898). Adjunctive low-voltage area ablation reduced atrial tachyarrhythmia recurrence compared to PVI alone (RR 0.768; 95% CrI 0.655-0.898), without increasing serious complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: